Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for TTR gene editing and treating ATTR amyloidosis

Compositions and methods for TTR gene editing and treating ATTR amyloidosis

US Patent 11795460 · Granted Oct 24, 2023

Estimated economic value: $27,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for kallikrein (KLKB1) gene editing2025
Compositions and methods for kallikrein (KLKB1) gene editing2025
Compositions and methods for treating alpha-1 antitrypsin deficiency2025
Compositions and methods for treating alpha-1 antitrypsin deficiency2025
Compositions and methods for treating alpha-1 antitrypsin deficiency2025
Modified guide RNAs2024
Compositions and methods for immunooncology2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024